Publications by authors named "Y Nishiya"
Background: We investigate the feasibility of using artificial intelligence (AI) to identify the recurrent laryngeal nerve (RLN) during endoscopic thyroid surgery and evaluated its accuracy.
Methods: In this retrospective study, we develop an AI model using a dataset of endoscopic thyroid surgery videos, including hemithyroidectomy procedures performed between April 2019 and September 2023 at the National Cancer Center Hospital East, Chiba, Japan. Semantic segmentation deep learning methods were applied to analyze the endoscopic thyroid surgery videos.
Objective: Reports of endoscopic surgery for squamous cell carcinoma of the nasal cavity and ethmoid sinus are limited. Herein, we present a comprehensive account of the results obtained from performing endoscopic surgery based on the concept of en bloc resection.
Methods: This was a retrospective observational study of patients who underwent nasal endoscopic surgery for squamous cell carcinoma of the nasal cavity and ethmoid sinus at a hospital between July 2018 and December 2021.
Article Synopsis
- Enhanced recovery after surgery programs are designed to decrease surgery-related invasiveness and improve recovery, with early enteral nutrition and mobilization being key elements, though their safety in head and neck surgery remains uncertain.
- A retrospective study comparing conventional and early management methods found that early management significantly reduced major complications and wound infections in patients undergoing head and neck surgery with free tissue transfer.
- While the early management group showed slightly lower compliance rates compared to the conventional group, the study concluded that early management is a safe and effective approach to enhance postoperative recovery in this surgical context.
N-Methylisothiazolinone (MIT) is a thiol group modifier and antimicrobial agent. Arthrobacter sarcosine oxidase (SoxA), a diagnostic enzyme for assaying creatinine, loses its activity upon the addition of MIT, and its inactivation mechanism remains unclear. In this study, SoxA was chemically modified using MIT (mo-SoxA), and its structural and chemical properties were characterized.
View Article and Find Full Text PDFArticle Synopsis
- Volume overload is a serious issue for patients on peritoneal dialysis (PD), and traditional treatments often fall short, leading researchers to explore SGLT2 inhibitors as a potential new solution.
- The EMPOWERED trial will investigate if the SGLT2 inhibitor empagliflozin can increase ultrafiltration volume in patients with chronic heart failure who use glucose-based PD solutions.
- Results from this trial could provide valuable insights into fluid management and the impact of SGLT2 inhibitors on overall kidney function in PD patients.